Evidence map›Paper›PMID 39742273›Full record

ArticleFrontiers in immunology2024

The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis.

Femke Van Gaever, Fleur Mingneau, Sam Vanherle, Yasmine Driege, Mira Haegman, Elien Van Wonterghem, Junhua Xie, Roosmarijn E Vandenbroucke, Jerome J A Hendriks, Rudi Beyaert and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Femke Van GaeverVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Fleur MingneauDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Sam VanherleDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Yasmine DriegeVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Mira HaegmanVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Elien Van WonterghemVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Junhua XieVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Roosmarijn E VandenbrouckeVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Jerome J A HendriksDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Rudi BeyaertVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.
Jens StaalVIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Over the past few decades, there has been a sudden rise in the incidence of Multiple Sclerosis (MS) in Western countries. However, current treatments often show limited efficacy in certain patients and are associated with adverse effects, which highlights the need for safer and more effective therapeutic approaches. Environmental factors, particularly dietary habits, have been observed to play a substantial role in the development of MS. In this study, we are the first to investigate the potential protective effect of the phytohormone abscisic acid (ABA) in MS. ABA, which is abundant in fruits such as figs, apricots and bilberries, is known to cross the blood-brain barrier and has demonstrated neuroprotective effects in conditions like depression and Alzheimer's disease. Methods: In this study, we investigated whether ABA supplementation enhances remyelination in both Results: Our results indicated that ABA enhanced remyelination and that this enhanced remyelination is associated with increased lipid droplet load, reduced levels of degraded myelin, and a higher abundance of F4/80+ cells in the demyelinated brain of mice treated with ABA. In Conclusion: Our findings highlight a crucial role for macrophages and microglia in enabling ABA to enhance the remyelination process. Furthermore, ABA's ability to improve remyelination together with its ability to reduce microglial activation, make ABA a promising candidate for modulating macrophage phenotype and reducing neuroinflammation in MS.

Indexed as

Abscisic AcidDisease Models, AnimalMultiple SclerosisRemyelinationAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleMiceMice, Inbred C57BLMicrogliaMyelin SheathPlant Growth RegulatorsAbscisic AcidPlant Growth Regulatorsabscisic acidmacrophagesmicrogliamultiple sclerosismyelinneuroinflammationremyelination

Identifiers

PMID39742273
PMCPMC11685095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.